Sanjay Jhawar, M.D. - PubMed

Dr. Jhawar studies pulmonary morbidity in children with systemic lupus erythematosus and other connective disorder; leukocyte chemotaxis; and chronic pulmonary inflammation.

Rory Kretzmer, M.D. - PubMed

Dr. Kretzmer’s previous work has focused on the use of long-term ventilation in children with chronic respiratory failure as well as in primary care screening practices for sleep disorders in neurodiverse populations with autism spectrum disorder. Since joining UC Davis, his work has focused on quality improvement and research-based approaches to the use of telehealth including video visits, telemonitoring, and virtual support groups in asthma and other conditions treated by pediatric pulmonologists. He collaborates on multi-institutional patient centered outcomes-based projects for patients with Robin Sequence (a congenital airway anomaly) and is the site principal investigator for two clinical trials aimed at the prevention and treatment of respiratory syncytial virus (RSV) respiratory tract infections in infants and children.

Kiran Nandalike, M.D. - PubMed

Dr. Nandalike’s active projects include the utility of limited sleep studies in the inpatient pediatric setting along with sleep apnea and sleep quality screening in pediatric cystic fibrosis patients.

Dr. Nandalike is the pediatric director for the TDN (therapeutic development network) research network, which conducts various cystic fibrosis related clinical trials. They currently finished recruiting patients for Vertex 445 clinical trial and are currently recruiting patients for AeroVanc phase 3 clinical trial.

Kent Pinkerton, M.D. - PubMed

Dr. Pinkerton’s research interests are in air pollution and early perinatal development.  Exposure to secondhand smoke and e-cigarette vapors are active areas of research.  Environmental exposures in atopic mothers during pregnancy are underway to examine cardiorespiratory and neurological consequences in offspring.

Shaina Willen, M.D. - PubMed

The goal of my research is to enhance our understanding of the risk factors and pathophysiology of lung disease in individuals with sickle cell disease. Specifically, I have investigated the overlap of sickle cell disease and asthma, changes in lung function measurements, and biomarkers of lung injury in adults and children with sickle cell disease. I am also working to understand the impact of environmental pollutants on disease related complications in individuals with sickle cell disease.